IRIS

Acetochlor

CASRN 34256-82-1

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (14 pp, 126 K) last updated: 09/01/1993

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Nervous, Reproductive, Hepatic, Urinary, Hematologic 2 x 10-2 Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and decreased blood glucose levels; histopathological changes in kidneys and testes of males NOAEL : 2
mg/kg-day
100 High

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (14 pp, 126 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (14 pp, 126 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (14 pp, 126 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (14 pp, 126 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.